'Policy support important as India largely an out-of-pocket mkt
Business Standard|October 07, 2024
British drug major AstraZeneca is working on several clinical trials and several cancer-related projects in India. The company is trying to bring in technology to speed up the introduction of its global products. AstraZeneca Pharma India Managing Director and Country President SANJEEV PANCHAL talks to Shine Jacob about the company's future plans in an interview in Chennai. Edited excerpts.
Shine Jacob
'Policy support important as India largely an out-of-pocket mkt

With your global plans to reach $80 billion in revenue by 2030, what will be the Indian market's contribution to that?

We achieved around $45 billion in sales last year globally, and almost $10 billion was invested in research and development.

Our mission is to bring to India the new assets launched globally as quickly as possible. That would define how much we can contribute to this global ambition. For example, in 2023, we announced we would bring 15 new launches or a combination of new assets to India by 2025. We have received approval to launch nine of those 15. We are bringing these assets to the country, and that will contribute to global ambitions.

Over the past 45 years, we have strengthened our footprint, including the Global Innovation and Technology Centre (GITC), which helps bring medicines faster and supports over 100 countries. We see this market as India for India, and India for the world through such centres. We want to be pioneers in science.

What is your strategy regarding the launch of early diagnosis products for cancer?

هذه القصة مأخوذة من طبعة October 07, 2024 من Business Standard.

ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.

هذه القصة مأخوذة من طبعة October 07, 2024 من Business Standard.

ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.

المزيد من القصص من BUSINESS STANDARD مشاهدة الكل
Business Standard

A singular life in plural India

In India today it is difficult to imagine a period of uninterrupted communal harmony, with reports of lynching, hate speech and bigotry surfacing with rising frequency.

time-read
3 mins  |
December 21, 2024
11 dead in fire after LPG tanker crashes into vehicles on Jaipur-Ajmer highway
Business Standard

11 dead in fire after LPG tanker crashes into vehicles on Jaipur-Ajmer highway

An LPG tanker collided with a truck on Friday, sparking a massive fireball that turned a stretch of the Jaipur-Ajmer highway into an inferno in which 11 people were killed and 37 vehicles engulfed in flames.

time-read
1 min  |
December 21, 2024
FMCG firms roll out tailored offerings for golden years
Business Standard

FMCG firms roll out tailored offerings for golden years

Affluent and health conscious, mature consumers are becoming selective about what they buy. Businesses are stepping up to meet their needs

time-read
2 mins  |
December 21, 2024
SPHERES OF INFLUENCE
Business Standard

SPHERES OF INFLUENCE

New districts are being announced more because of demands by influential groups than empirical studies, usually in the buildup to elections

time-read
4 mins  |
December 21, 2024
Accenture Q1 showing a shot in arm for IT stocks
Business Standard

Accenture Q1 showing a shot in arm for IT stocks

Strong US economy bodes well for Indian IT firms, say analysts

time-read
2 mins  |
December 21, 2024
Sun Pharma: Down, but not out
Business Standard

Sun Pharma: Down, but not out

Despite short-term blip, pharma major remains favourite among investors

time-read
3 mins  |
December 21, 2024
Business Standard

Mirae Asset MF's AUM crosses ₹2 trn mark

Mirae Asset Investment Managers (India) on Friday announced that its mutual fund (MF) assets under management (AUM) has crossed the ₹2 trillion mark on the back of 54 per cent compound annual growth rate (CAGR) in the past five years.

time-read
1 min  |
December 21, 2024
Business Standard

PIL in HC seeks action against Amfi for 'misleading' ads

A public interest litigation (PIL) has been filed in the Bombay High Court seeking directions to Securities and Exchange Board of India (Sebi) to revoke the permissions granted to mutual fund body Association of Mutual Funds in India (Amfi) for \"misleading\" and \"deceptive\" advertisement campaigns under the investor education and protection measures.

time-read
1 min  |
December 21, 2024
IPO frenzy: Six issues fully subscribed; IGI at 13% premium on listing day
Business Standard

IPO frenzy: Six issues fully subscribed; IGI at 13% premium on listing day

The initial public offerings (IPOs) of DAM Capital Advisors, Sanathan Textiles, Concord Enviro Systems, Mamata Machinery and Transrail Lighting, whose issues are on their penultimate day, were subscribed between 1.24 and 37.75 times.

time-read
1 min  |
December 21, 2024
Debt funds to deliver best show in 4 yrs
Business Standard

Debt funds to deliver best show in 4 yrs

Strong performance attributed to bond index inclusion and fiscal prudence, say experts

time-read
3 mins  |
December 21, 2024